|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/16/20 AVROBIO, Inc. 10-K 12/31/19 85:8.4M ActiveDisclosure/FA |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 1.15M
2: EX-4.3 Instrument Defining the Rights of Security Holders HTML 53K
5: EX-10.16 Material Contract HTML 94K
3: EX-10.7 Material Contract HTML 49K
4: EX-10.8 Material Contract HTML 38K
6: EX-21.1 Subsidiaries List HTML 25K
7: EX-23.1 Consent of Experts or Counsel HTML 30K
8: EX-31.1 Certification -- §302 - SOA'02 HTML 35K
9: EX-31.2 Certification -- §302 - SOA'02 HTML 35K
10: EX-32.1 Certification -- §906 - SOA'02 HTML 30K
17: R1 Document and Entity Information HTML 95K
64: R2 Consolidated Balance Sheets HTML 84K
72: R3 Consolidated Balance Sheets (Parenthetical) HTML 45K
46: R4 Consolidated Statements of Operations and HTML 68K
Comprehensive Loss
18: R5 Consolidated Statements of Redeemable Convertible HTML 100K
Preferred Stock and Stockholders' (Deficit) Equity
65: R6 Consolidated Statements of Redeemable Convertible HTML 30K
Preferred Stock and Stockholders' (Deficit) Equity
(Parenthetical)
73: R7 Consolidated Statements of Cash Flows HTML 108K
45: R8 Nature of the Business HTML 34K
19: R9 Summary of Significant Accounting Policies HTML 106K
84: R10 Fair Value of Financial Assets and Liabilities HTML 123K
61: R11 Prepaid Expenses and Other Current Assets HTML 55K
33: R12 Property and Equipment, Net HTML 54K
41: R13 Accrued Expenses HTML 49K
83: R14 Loan Agreement and Warrant to Purchase Preferred HTML 31K
Stock
60: R15 Redeemable Convertible Preferred Stock HTML 30K
32: R16 Common Stock HTML 64K
40: R17 Stock-Based Compensation HTML 145K
85: R18 License Agreements HTML 50K
59: R19 Income Taxes HTML 126K
22: R20 Net Loss per Share Attributable to Common HTML 47K
Stockholders
48: R21 Commitments and Contingencies HTML 48K
71: R22 Related Party Transactions HTML 32K
63: R23 Benefit Plans HTML 30K
21: R24 Subsequent Events HTML 30K
47: R25 Summary of Significant Accounting Policies HTML 171K
(Policies)
70: R26 Summary of Significant Accounting Policies HTML 50K
(Tables)
62: R27 Fair Value of Financial Assets and Liabilities HTML 123K
(Tables)
20: R28 Prepaid Expenses and Other Current Assets (Tables) HTML 56K
49: R29 Property and Equipment, Net (Tables) HTML 53K
43: R30 Accrued Expenses (Tables) HTML 49K
34: R31 Common Stock (Tables) HTML 64K
56: R32 Stock-Based Compensation (Tables) HTML 139K
81: R33 Income Taxes (Tables) HTML 118K
44: R34 Net Loss per Share Attributable to Common HTML 46K
Stockholders (Tables)
35: R35 Commitments and Contingencies (Tables) HTML 40K
58: R36 Nature of the Business - Additional Information HTML 38K
(Detail)
82: R37 Summary of Significant Accounting Policies - HTML 45K
Additional Information (Detail)
42: R38 Summary of Significant Accounting Policies - HTML 36K
Estimated Useful Lives of Property and Equipment
(Detail)
36: R39 Summary of Significant Accounting Policies - HTML 38K
Statements of cash flows subsequent to the
adoption of ASU (Detail)
51: R40 Fair Value of Financial Assets and Liabilities - HTML 38K
Summary of Financial Assets and Liabilities
Measured at Fair Value on Recurring Basis (Detail)
23: R41 Fair Value of Financial Assets and Liabilities - HTML 43K
Additional Information (Detail)
68: R42 Fair Value of Financial Assets and Liabilities - HTML 36K
Summary of Changes in Fair Value of Preferred
Stock Warrant Liability for Fair Value Determined
by Level 3 Inputs (Detail)
76: R43 Fair Value of Financial Assets and Liabilities - HTML 36K
Summary of Changes in Fair Value of Derivative
Liability for Fair Value Determined by Level 3
Inputs (Detail)
52: R44 Prepaid Expenses and Other Current Assets - HTML 45K
Summary of Prepaid Expenses and Other Current
Assets (Detail)
24: R45 Property and Equipment, Net - Summary of Property HTML 42K
and Equipment, Net (Detail)
69: R46 Property and Equipment, Net - Additional HTML 29K
Information (Detail)
77: R47 Accrued Expenses - Summary of Accrued Expenses HTML 40K
(Detail)
50: R48 Loan Agreement and Warrant to Purchase Preferred HTML 60K
Stock - Additional Information (Detail)
25: R49 Redeemable Convertible Preferred Stock - HTML 60K
Additional Information (Detail)
30: R50 Common Stock - Additional Information (Detail) HTML 62K
38: R51 Common Stock - Summary of Common Stock Reserved HTML 41K
for Future Issuance (Detail)
80: R52 Stock-Based Compensation - Additional Information HTML 72K
(Detail)
55: R53 Stock-Based Compensation - Summary of Assumptions HTML 35K
that Used to Determine Grant-Date Fair Value of
Stock Options Granted to Employees and Members of
Board (Detail)
29: R54 Stock-Based Compensation - Summary of Stock Option HTML 64K
Activity (Detail)
37: R55 Stock-Based Compensation - Summary of Restricted HTML 43K
Stock Unit Activity (Detail)
79: R56 Stock-Based Compensation - Schedule of Stock-based HTML 34K
Compensation Expense (Detail)
54: R57 License Agreements - Additional Information HTML 91K
(Detail)
28: R58 Income Taxes - Additional Information (Detail) HTML 76K
39: R59 Income Taxes - Schedule of Reconciliation of HTML 54K
Income Tax Expense (Benefit) (Detail)
75: R60 Income Taxes - Schedule of Deferred Tax Assets and HTML 57K
Liabilities (Detail)
67: R61 Net Loss per Share Attributable to Common HTML 33K
Stockholders - Schedule of Dilutive Common Stock
Equivalents Excluded from Computation of Diluted
Net Loss per Share (Detail)
27: R62 Commitments and Contingencies - Additional HTML 41K
Information (Detail)
53: R63 Commitments and Contingencies - Schedule Of Future HTML 40K
Minimum Rental Payment Under Operating Lease
(Detail)
74: R64 Related Party Transactions - Additional HTML 47K
information (Detail)
66: R65 Benefit Plans - Additional Information (Detail) HTML 30K
26: R66 Subsequent Events - Additional Information HTML 43K
(Detail)
31: XML IDEA XML File -- Filing Summary XML 150K
57: EXCEL IDEA Workbook of Financial Reports XLSX 87K
11: EX-101.INS XBRL Instance -- avro-20191231 XML 1.75M
13: EX-101.CAL XBRL Calculations -- avro-20191231_cal XML 142K
14: EX-101.DEF XBRL Definitions -- avro-20191231_def XML 475K
15: EX-101.LAB XBRL Labels -- avro-20191231_lab XML 1.21M
16: EX-101.PRE XBRL Presentations -- avro-20191231_pre XML 901K
12: EX-101.SCH XBRL Schema -- avro-20191231 XSD 185K
78: ZIP XBRL Zipped Folder -- 0001564590-20-011144-xbrl Zip 149K
Exhibit 31.2
CERTIFICATION PURSUANT TO
RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Erik Ostrowski, certify that:
|
1. |
I have reviewed this Annual Report on Form 10-K of AVROBIO, Inc.; |
|
2. |
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
|
3. |
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
|
4. |
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
|
|
(a) |
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
|
|
(b) |
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
|
|
(c) |
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
|
|
(d) |
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
|
5. |
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
|
|
(a) |
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
|
|
(b) |
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting |
|
Date: March 16, 2020 |
|
By: |
|
/s/ Erik Ostrowski |
|
|
|
|
|
|
|
|
|
|
|
Chief Financial Officer (Principal Financial Officer) |
| This ‘10-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 3/16/20 | 8-K, S-8 | ||
| For Period end: | 12/31/19 | 5 | ||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/29/24 AVROBIO, Inc. S-4/A 80:15M Donnelley … Solutions/FA 4/15/24 AVROBIO, Inc. S-4/A 91:17M Donnelley … Solutions/FA 3/26/24 AVROBIO, Inc. S-4/A 3/25/24 89:18M Donnelley … Solutions/FA 3/14/24 AVROBIO, Inc. 10-K 12/31/23 80:9.4M Donnelley … Solutions/FA 2/14/24 AVROBIO, Inc. S-4 91:25M Donnelley … Solutions/FA 3/23/23 AVROBIO, Inc. 10-K 12/31/22 82:10M Donnelley … Solutions/FA 11/08/22 AVROBIO, Inc. S-3 8:1.8M Broadridge Fin’l So… Inc 3/17/22 AVROBIO, Inc. 10-K 12/31/21 78:9.1M ActiveDisclosure/FA 3/18/21 AVROBIO, Inc. 10-K 12/31/20 73:9.1M ActiveDisclosure/FA 11/20/20 AVROBIO, Inc. 424B5 1:5.2M Donnelley … Solutions/FA 11/19/20 AVROBIO, Inc. 424B5 1:5.1M Donnelley … Solutions/FA |